Seed VC · France

Jeito Capital

Active

What they invest in

Jeito finances and accelerates cutting-edge medical innovation through a patient-benefit-focused approach, supporting entrepreneurs with multidisciplinary expertise across the entire drug value chain and significant capital to ensure company growth.

Who they back

DeepTechHealthtechBiotechSeries ASeries B+

Business models

biotech_therapeutics, deeptech_ip

Customer segments

Researchers, Enterprise

Geography

Europe, US, UK

Recent investments

  • Adcendo
  • Alveus Therapeutics
  • Odyssey Therapeutics

+ 3 more deals. Score your deck to see the full investment history.

The people who write checks

6 partners on file at Jeito Capital, with the firm's email pattern for cold outreach. Score your deck (free, 30 seconds) to unlock direct contact for this firm and 47,000+ others.

We never publish partner emails directly. Score your deck to unlock contacts for the firms ranked as best-fit.

Why this firm matters for fundraising founders

Jeito Capital writes first institutional checks where the founder + early product matter more than traction. The seed market is the most dispersed segment of venture; matching to thesis (sector, stage, geography) is where most cold outreach succeeds or fails. VC Boom tracks Jeito Capital alongside 47,000+ other active investors, ranked weekly by recent-deal momentum, sector concentration, and partner activity.

At a glance

Based in
France
Last known deal
Jan 2020
Portfolio last checked
Oct 11, 2026
Website
www.jeito.life ↗

Other firms investing in DeepTech

See all investors

Is Jeito Capital the right fit for your deck?

Drop your pitch. VC Boom scores it on the 8 dimensions VCs read for and ranks the 47,000+ active investors in the database by fit. Jeito Capital is one of them, and we'll tell you exactly where they sit in your top 100.